Clinical Trials

    Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

    Investigator: Carrie Yuen

    Study Coordinator: Danielle Sewall

    Status: Enrolling

    ClinicalTrials.gov Number: NCT06022939

    Phone: 346.238.2674

    Protocol Number: PRO00038339

    Description


    This phase III trial compares the effect of adding a stem cell transplant with melphalan after completing chemotherapy with daratumumab, cyclophosphamide, bortezomib and dexamethasone (Dara-VCD) versus chemotherapy with Dara-VCD alone for treating patients with newly diagnosed amyloid light chain (AL) amyloidosis.